Insilico Medicine Joins Hang Seng Index and Stock Connect Program: A Milestone in Biotech Innovation
Insilico Medicine, a trailblazing clinical-stage biotechnology firm driven by generative artificial intelligence (AI), has reached a pivotal milestone by securing ...
